Signal— New Insights into ATMP Valuation and Outcomes-Based Pricing Experience
Partner with ISPOR on September 27 as the Society launches the eighth Signal Series episode focusing the Danish experience with ATMP valuation approach and development of an innovative outcomes-based pricing agreement between pharma and payers.
The Signal series seeks to improve understanding by integrating a variety of scientific disciplines and investigating innovative thinking that can improve healthcare decisions. Signal focuses on the “big picture,” while also addressing how health economics and outcomes research can best contribute to solving healthcare’s greatest challenges.
Explore a creative approach and partner with ISPOR to advance thought leadership through addressing novel topics that drive innovation in HEOR. Think beyond traditional HEOR frameworks and explore important developments in other sectors of the economy and other disciplines that will impact decision-making for health in the next decade.
A limited number of sponsorship opportunities are available for the strategic-level, thought-provoking, and conversation-generating Signal Series.